 |
|
|
| |
Pharmacokinetics and Tolerability of Cabotegravir and Rilpivirine Long-Acting Intramuscular Injections to the Vastus Lateralis (Lateral Thigh) Muscles of Healthy Adult Participants
|
| |
| |
AIDS 2022 July 29 - Aug 1 Montreal
Kelong Han1, Jafar Sadik Shaik1, Herta Crauwels2, Claudia Leemereise3, Gilda Bontempo4, Beta Win5, Ciara Seal1, Rebecca DeMoor1, Ojesh Upadhyay1, Vasiliki Chounta6, William R. Spreen4, Susan L. Ford7
1GlaxoSmithKline, Collegeville, PA, United States; 2Janssen Research & Development, Beerse, Belgium; 3GlaxoSmithKline, Amersfoort, the Netherlands; 4ViiV Healthcare, Research Triangle Park, NC, United States; 5GlaxoSmithKline, Stevenage, United Kingdom; 6ViiV Healthcare, Brentford, United Kingdom; 7GlaxoSmithKline, Research Triangle Park, NC, United States.
|
| |
|
|
|
|
|
